Neurogene Therapeutics (NGNE) Cash Funds per Single Share

Neurogene Therapeutics - graphic logo of issuer NGNE

Neurogene Inc. is developing precision gene therapies, securing patents for Rett syndrome treatments. Its own US-based manufacturing facility ensures the production of complex biologics, although high R&D expenditures are depleting reserves. The cash per share trend demonstrates the current margin of safety, while the 17.41 metric reflects the current market value of this liquid asset.

Cash per Single Share: Neurogene Corp (NGNE) for 02/21/2024 - 11/20/2026

Comprehensive metric breakdowns and analytics for neurogene.com (NGNE)

- market value and analyst target forecast:
- cash availability and cash flow indicators:
Comprehensive company analysis:Neurogene Corp NGNE
Product sample of Neurogene Inc.

Investors must assess the bankruptcy risk of Neurogene Inc. (NGNE), given the lack of stable revenues in the clinical gene therapy sector. An analysis of cash per share allows for the determination of the actual liquidity reserve per unit, which serves as a critical indicator of business viability prior to drug commercialization and confirms its operational resilience against macroeconomic shocks.

Key competitors

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|RGC - Cash on Hand per Share|Cash Funds per Share Axsome Therapeutics AXSM|Cash per Share ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Cash per Share|Cash on Hand per Share Viking Therapeutics|SUPN: Cash per Share|Catalyst Pharmaceuticals (CPRX) - Cash per Share|Cash per Single Share DNLI|Cash Funds per Single Share HRMY (Harmony Biosciences Holdings, Inc.)|Cash Funds per Share Biohaven Ltd. (BHVN)|Cash Calculated per Single Share AMLX|Cash Funds per Share trevitherapeutics.com TRVI|PRAX - Cash per Single Share|Anavex Life Sciences Corp - Cash per Share|Cash on Hand per Share CeriBell Corp|Prothena Corporation PLC (PRTA) - Cash Funds per Share|Alector Therapeutics - Amount of Cash per Share|Cash Funds per Share Annexon Biosciences|Cash on Hand per Share omeros.com OMER|Cash per Share ACIU|VYGR - Cash on Hand per Share|Cash Funds per Share Neumora Therapeutics Inc NMRA|Cash Funds Calculated per Share Scilex Holding Co. (SCLX)|TVGN - Cash Funds per Share|Cash on Hand per Share alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Cash per Single Share|IKT: Cash Calculated per Single Share|Cash Funds per Share Cassava Sciences, Inc.|ASRT (assertiotx.com) - Cash Calculated per Single Share|Cash Funds per Share Coya (COYA)|VTGN - Cash on Hand per Share|Cash per Share OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Cash on Hand per Share|cervomed.com - Cash per Share|Amount of Cash per Share ATHE (Alterity Therapeutics Limited)|CLNN: Cash per Share|Cash per Single Share PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Cash per Share|Cash on Hand per Share Relmada Therapeutics Inc RLMD|Cash Funds per Share Annovis Bio Corporation (ANVS)|GRCE - Cash on Hand per Share|Cash Funds per Share Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Cash on Hand per Share|NeuroSense Therapeutics, Ltd. - Cash per Share|RVPH: Cash Funds per Share|MTVA: Cash per Share|NRXS - Cash Funds Calculated per Share|HSDT (Helius Medical Technologies Inc.) - Cash per Share|Cash on Hand per Share Passage Bio PASG|Cash Funds per Share Neuphoria (NEUP)|Cash per Share Minerva Neurosciences Corp (NERV)|Cash Funds per Share Athira ATHA|Cash per Share Addex ADXN|Alzamend - Cash per Share|Cash on Hand per Share Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Cash Funds per Share|KTTA: Cash Calculated per Single Share|Cash per Single Share CRGT|Avenue Therapeutics, Inc - Cash Money per Share|Cash Funds per Share Brainstorm Cell (BCLI)|CARA: Cash Money per Share|Chromocell Therapeutics Corp. - Cash per Single Share|Cash Funds Calculated per Share Eliem (ELYM)|ITCI: Cash per Single Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share